The study results are being presented at the 2018 San Antonio Breast ... (SABCS) which is being held December 4-8, 2018 in San Antonio, Texas. ... KEYWORD: HEALTH BIOTECHNOLOGY ONCOLOGY PHARMACEUTICAL.
News
- Samsung Bioepis Announces Results of Additional One-Year Follow-Up Study Comparing Event ...
- Bb Biotech Ag Has Trimmed Its Regeneron Pharmaceuticals (REGN) Position; Oberweis Asset ...
Bb Biotech Ag decreased Regeneron Pharmaceuticals Inc. (REGN) stake by ... Bb Biotech Ag sold 10,000 shares as Regeneron Pharmaceuticals Inc. .... Energy for project at Joint Base San Antonio – Seeking Alpha” published on ...
- Moderna is sliding in its Wall Street debut after the biggest IPO in biotech history (MRNA, TBIO)
Moderna Therapeutics just started trading, after the biggest initial public offering in biotech history. The stock slid 5.7 percent to $21.65 in its trading ...
- Myriad study shows breast cancer recurrence test can predict therapy responses
The studies were presented at the San Antonio Breast Cancer Symposium. A retrospective analysis of five prospective studies evaluated 3,746 ...
- Leaders in SA biotech, military medicine to meet in inaugural summit
Several of San Antonio's heavy hitters in bioscience plan to meet with their military counterparts in the Alamo City in an effort to develop deeper ...